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SUMMARY
The effects of infusions of adrenaline, noradrenaline and dopamine on cerebral autoregulation under steady-state
isoflurane anaesthesia were compared with the awake state. 
Six studies each were conducted in two cohorts of adult ewes: awake sheep and those anaesthetized with 2%
isoflurane anaesthesia. In random order, each animal received ramped infusions of adrenaline, noradrenaline 
(0-40 µg/min) and dopamine (0-40 µg/kg/min). 
Cerebral blood flow was measured continuously from changes in Doppler velocities in the sagittal sinus.
Autoregulation was determined by linear regression analysis between cerebral blood flow and mean arterial pressure.
Isoflurane did not significantly alter cerebral blood flow relative to pre-anaesthesia values (P>0.05). All three
catecholamines significantly and equivalently increased MAP from baseline in a dose dependent manner in both the
awake and isoflurane cohorts. Although adrenaline significantly increased cerebral blood flow from baseline in the
awake cohort (P<0.01), none of the catecholamines significantly increased cerebral blood flow during isoflurane
anaesthesia. No significant differences were demonstrated between the slopes and intercepts of regression lines for
adrenaline, noradrenaline and dopamine within either cohort (ANCOVA). Inter-cohort comparisons between the two
autoregulation curves demonstrated no significant difference between the slopes of the autoregulation curves for the
awake (pooled slope=0.39) and isoflurane cohorts (pooled slope=0.28) (P>0.05).
Over a specific dose range, systemic hypertension induced by adrenaline, noradrenaline and dopamine did not
significantly increase cerebral blood flow under 2% isoflurane anaesthesia. The concomitant administration of
isoflurane and the catecholamines was not associated with altered autoregulatory function compared to the awake
state. 
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Cerebral autoregulation is defined as the main-
tenance of cerebral blood flow at constant levels in
the presence of changing systemic pressures. Also
termed “myogenic” autoregulation, this phenomenon
is attributed to changes in cerebrovascular resistance,
although a number of metabolic systems have been
implicated1. The capacity of this complex physio-
logical system to maintain cerebral autoregulation
may be influenced by volatile anaesthetic agents2-4. 
Infusions of catecholamines such as adrenaline,
noradrenaline and dopamine are frequently used
during anaesthesia to defend systemic blood pres-
sure. During neuroanaesthetic procedures using
volatile agents such as isoflurane, these cate-
cholamines may also be used to augment or maintain
cerebral perfusion pressure. 
Volatile anaesthetics have variable effects on
cerebral blood flow and autoregulation. Under these
conditions, catecholamines may exert direct or in-
direct effects on the cerebral circulation, which may
result in alterations in cerebral autoregulatory
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activity5. The direct effect of catecholamines on the
cerebral circulation under awake and anaesthetized
conditions remains contentious, due to variability of
experimental models and methods of measurement
of cerebrovascular mechanics.
The aim of this study was to determine the effects
of adrenaline, noradrenaline and dopamine on cere-
bral autoregulation under steady-state isoflurane
anaesthesia. These effects were compared with each
other and with awake animals state.
The Animal Ethics Committee of the University 
of Adelaide approved the studies. Animals were
handled in accordance with the 1997 edition of the
Australian Code of Practice for the Care and Use 
of Animals for Scientific Purposes issued by the
National Health and Medical Research Council of
Australia.
METHOD
Studies were performed in two cohorts of adult
female merino sheep: awake and anaesthetized with
steady-state isoflurane.
Animal preparation
Adult merino ewes of similar ages and body mass
were used. One to two weeks prior to performing the
studies, the animals were instrumented under
thiopentone and halothane anaesthesia as described
previously6. In brief, a 2 cm frontal craniotomy was
performed anterior to the trifurcation of the frontal
and parietal sutures. A bony plug was removed using
a trephine and the extradural portion of the sagittal
sinus exposed. 
An ultrasonic, range-gated Doppler transducer
(Tritonics Medical Instruments, Iowa, U.S.A.) was
placed on the dorsal sagittal sinus. The Doppler
transducer was secured under the replaced bone plug
that was fixed with a plate and bone screws. 
The animal was then turned supine and the
femoral triangle exposed. A 7F catheter (Multi-
purpose A1 catheter, Cordis Corporation, Miami,
U.S.A.) was inserted into the femoral artery for
measurement of mean arterial pressure and into the
femoral vein for drug and fluid delivery. 
A single dose of penicillin/streptomycin was
administered perioperatively for antibiotic prophy-
laxis. Catheter patency was maintained by intra-
luminal heparin (10 IU/ml) locks.
The animal was then recovered and returned to
housing crates and allowed free access to food and
water.
A period of five to ten days elapsed between inser-
tion and measurements to allow a fibrous scar to
develop around the flowmeter and the sagittal sinus.
This ensured minimal movement between the two
and a constant angle between the ultrasonic beam
and the direction of blood flow.
The sample size required to determine baseline
stability within and between cohorts and repro-
ducibility of each intervention was determined from
previous studies using our experimental prepara-
tion7,8. Due to the homogeneity and stability of 
the preparation, six studies for each intervention 
(i.e. catecholamine infusion) were considered
appropriate. Stability and reproducibility were
evaluated by determining normality of distribution
and 95% confidence interval analysis. 
On the day of measurement, the animal was moved
to a specific study laboratory.
The animal was supported by a canvas sling and
extraneous noise was minimized to reduce changes in
cerebral blood flow induced by startling. Monitoring
lines were connected and the animal was allowed to
settle so that a period of baseline stability was
achieved before commencement of infusions.
Prior to anaesthesia, the output of the Doppler
probe and mean arterial pressure catheter was
recorded with the animal in an awake, calm state.
Anaesthesia was induced with thiopentone 1000mg
and isoflurane delivered by a vaporizer (Isotec 3,
Ohmeda BOC Group, U.K.) in 100% oxygen to
maintain an expired concentration of 2%, measured
by a volatile agent detector (Capnomac, Datex
Instrumentarium Corp, Helsinki, Finland).
Selection of isoflurane dose
Whilst minimum alveolar concentration (MAC)
has an established place in clinical anaesthesia and is
a useful method of comparing relative potencies of
anaesthetic agents, it has limitations in animal phar-
macokinetic or pharmacodynamic studies. A surgical
incision is a difficult stimulus to standardize and there
are cross species differences. Such pharmacodynamic
studies may be standardized by establishing a depth
of anaesthesia that may be assessed by reproducible
stimuli, such as with analgesiometry, or by performing
studies at variable levels of steady-state concentra-
tion9. These concentrations may be determined using
end-tidal expired gas concentrations of the volatile
agent in question with specific expired gas analysers.
The selection of 2% isoflurane was based on pre-
viously published animal studies using isoflurane that
demonstrated adequacy of anaesthesia and stability
of cerebrovascular volumes over a range of PaCO2 10.
The effects of isoflurane on carbon dioxide cerebro-
vascular reactivity in doses of 1.5% and 2% have been
described11. 
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The animal was turned supine and endotracheally
intubated. Ventilation was controlled using a volume
control ventilator (7000 Ventilator, Ohmeda, Madi-
son, WI, U.S.A.) in 100% oxygen. End-tidal CO2 was
measured with an infrared analyser (Capnomac,
Datex Instrumentarium Corp, Helsinki, Finland) 
and mechanical ventilation was adjusted to maintain
end-tidal CO2 at 40 mmHg. 
The animal was placed on the side position for
studies.
After 1.5 hours to allow the induction agent to
clear and assuming steady-state anaesthetic condi-
tions, baseline measurements of cerebral blood flow
and mean arterial pressure were recorded. This inter-
val has been determined in previous studies from our
laboratory12.
Interventions
In random order, each animal received a ramped
intravenous infusion of noradrenaline, adrenaline or
dopamine through the femoral venous catheter.
Noradrenaline and adrenaline were made up as 
3 mg/50 ml 0.9% saline. Using a syringe driver, a
delivery rate of 1 ml/h is equivalent to 1 µg/minute.
Dopamine was constituted as 200 mg/50 ml 0.9%
saline. A delivery rate of 1 ml/h is approximately
equivalent to 1 µg/kg/min for a 50 kg sheep. 
A dosing profile designed to produce a significant
physiological response was selected. Principally, this
was directed at significantly increasing mean arterial
pressure. As adrenaline and noradrenaline have
hydroxyl groups on the β carbon atom of the side
chain, this is associated with 100 times greater
potency than dopamine13. Consequently, the cate-
cholamine concentrations may be regarded as
functionally equivalent. Doses were reported as ml/h.
Catecholamines were administered as ramped
infusions in five minute intervals in doses of 10, 20
and 40 ml/h through the femoral venous catheter.
Each animal acted as its own control. On reaching the
target dose, infusions were ceased. An elimination
period of 15 minutes lapsed following catecholamine
infusion to ensure clearance of the preceding drug,
manifested by restoration of cardiovascular para-
meters to baseline values. Subsequent studies 
were conducted 60 minutes after completion of the
elimination period.
Hydration was maintained throughout all studies
by intravenous infusion of 1 litre per hour of normal
saline. Temperature was maintained at baseline levels
via humidification of inspired gases using a heat and
moisture exchanger.
Following the studies, the animal was recovered
and transferred to holding crates and allowed free
access to food and water.
Measurements
Changes in cerebral blood flow were inferred from
changes in the outputs from the Doppler probe. Once
a period of baseline stability was established, Doppler
frequencies were expressed as a percentage of the
reading obtained in the baseline period. This was
sampled at 1Hz using an analogue to digital card
(Metrabyte DAS 16-G2) and a personal computer
(Microbits 486-based IBM compatible) and recorded
digitally on computer disc. This method of quantify-
ing cerebral blood flow with a range-gated Doppler
ultrasound probe venous outflow has been validated
in sheep as a measure of global cerebral blood flow
against angiographic, retrograde dye and timed
venous outflow studies6. This method represents 75%
total cerebral blood flow and has been demonstrated
to be in agreement with measurements made using
the Kety-Schmidt nitrous oxide method in sheep14.
Due to the anatomical structure of the sagittal sinus
in sheep, this vessel in not subject to large variations
in vessel diameter. Over the range of flows studied,
constant correlation between flow and sinus blood
velocities is maintained.
Mean arterial pressure was recorded using a
standard transducer and amplifier (78342A, Hewlett
Packard Company, U.S.A.) and recorded through the
same computerized acquisition system. Following
zero calibration, mean arterial pressure was recorded
as mmHg and averaged over two minutes after the
change in catecholamine infusion rate. This was done
in accordance with the expected half-lives of the
catecholamines, namely five to seven minutes.
Blood was sampled for blood gas analysis from the
femoral arterial catheter and measured using a
standard blood gas analyser (ABL 625, Radiometer
Medical, Copenhagen, Denmark). Samples were
taken at five-minute intervals during the cate-
cholamine infusions for measurement of arterial
carbon dioxide tension to ensure normocapnia and
calibration of end-tidal carbon dioxide. 
Data analysis
Normal distribution of datapoints before para-
metric analyses was determined using the using the
Kolmogorov-Smirnov (KS) test. The effect of isoflu-
rane on cerebral blood flow (pre-anaesthesia vs 1.5
hours post anaesthesia) was examined using a paired
t-test.
Data for changes in cerebral blood flow and mean
arterial pressure over time for each catecholamine
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under each condition was averaged into five-minute
intervals using data compression and averaging soft-
ware programs. These values corresponded to the
changes in rates of infusion. 
The data for cerebral blood flow were normalized
to an arterial carbon dioxide tension of 35 mmHg to
remove the influences of small differences in carbon
dioxide tensions on cerebral blood flow. This was
done by determining the correlation between
cerebral blood flow and measured PaCO2 during 
the catecholamine infusions using linear regression
analysis. Cerebral blood flow measurements were
then adjusted using the derived slope and intercept
for a PaCO2 of 35 mmHg. The normalized values of
cerebral blood flow were subsequently adjusted by
the degree of change in cerebral blood flow induced
by isoflurane, and expressed as a percentage of
baseline. 
Comparison of the effects of catecholamines on
cerebral blood flow and mean arterial pressure from
baseline was determined using two-way analysis of
variance and Bonferroni corrections for multiple time
points. Significance was determined by 95% confi-
dence intervals, assuming a t-distribution. A P value
of <0.05 was considered to be statistically significant.
Cerebral autoregulation was defined as the change
in cerebral blood flow for change in mean arterial
pressure. This was determined using linear regression
analysis. Comparisons between regression lines were
determined using an analysis of covariance, using the
pooled data for each dataset. These analyses were
performed using a commercial statistical software
program (GraphPad Prism, GraphPad Software, San
Diego, California, U.S.A.). 
RESULTS
Studies with each catecholamine were conducted in
six animals for each catecholamine in the awake state
and under isoflurane anaesthesia. 
Isoflurane anaesthesia did not significantly change
cerebral blood flow (88.45% of baseline, P=0.39) or
mean arterial pressure (97.6% of baseline, P=0.76)
from pre-anaesthetized baseline. 
The effects of each catecholamine on cerebral
blood flow and mean arterial pressure are shown 
in Figure 1. All three catecholamines significantly
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FIGURE 1: The effects of infusions of adrenaline, noradrenaline and dopamine on mean arterial pressure (mmHg) (Figure 1a) and
normalised cerebral blood flow (expressed as % baseline) (Figure 1b) in awake sheep (left hand panels) and during steady state isoflurane
anaesthesia (2%) (right hand panel). Dose is expressed as ml/h. Data are expressed as mean±SEM. Asterisk (***) represents P<0.001 and
refers to adrenaline, noradrenaline and dopamine in Figure 1a; (*)= P<0.01 in Figure 1b above adrenaline.
increased mean arterial pressure from baseline in a
dose dependent manner (P<0.001) in both the awake
and isoflurane cohorts (Figure 1a). In the awake
cohort, only adrenaline significantly increased cere-
bral blood flow from baseline (P<0.01). During
isoflurane anaesthesia, none of the catecholamines
significantly increased cerebral blood flow from base-
line (P>0.05) (Figure 1b). There was no statistically
significant difference between the effects of each
catecholamine in any of the cohorts (P>0.05). 
Individual regression analyses between cerebral
blood flow and mean arterial pressure for adrenaline,
noradrenaline and dopamine under awake conditions
and during isoflurane are shown in Table 1. 
The resultant slopes and intercepts for each cate-
cholamine in each cohort were compared by analysis
of covariance. The P values for each comparison are
shown in Table 2.
No statistically significant difference between the
slopes for adrenaline, noradrenaline and dopamine
within each cohort were demonstrated (P>0.05).
Significant differences in intercepts were demon-
strated between dopamine and noradrenaline
(P=0.01) in the awake cohort; and between adrena-
line and noradrenaline (P=0.002) and adrenaline and
dopamine (P=0.03) in the isoflurane cohort.
The effects on the autoregulation curves for the
awake and isoflurane cohorts are shown in Figure 2.
The data is presented using pooled data for the three
catecholamines, as there was no significant difference
between the slopes for each catecholamine within
each cohort.
Comparisons between the two autoregulation
curves demonstrated that there was no significant
difference between the slopes of the awake (pooled
slope=0.39) and isoflurane cohorts (pooled slope=
0.28) (P=0.50). However, there was a statistically sig-
nificant difference between the intercepts (P=0.02)
of the two cohorts.
DISCUSSION
This study analysed the effects of catecholamine-
induced hypertension on cerebral autoregulation
during steady-state isoflurane anaesthesia. Using real
time measurements, we assessed the simultaneous
response of cerebral blood flow to dynamic increases
in mean arterial pressure. These autoregulatory
responses were compared to awake animals.
Cerebral autoregulation is a complex physiological
process, involving metabolic and myogenic mecha-
nisms. This study was designed to assess the relation-
ship between cerebral blood flow and mean arterial
pressure, using induced hypertension as the primary
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TABLE 1
Individual regression analyses for adrenaline, noradrenaline and dopamine under awake conditions and during steady-state isoflurane
anaesthesia (2%). Data for slope (cerebral blood flow % baseline/mmHg) and intercept (cerebral blood flow % baseline) are expressed as
mean±SEM
Awake Isoflurane 
Adrenaline Noradrenaline Dopamine Adrenaline Noradrenaline Dopamine
r2 0.81 0.16 0.59 0.86 0.87 0.62
Slope 0.53±0.18 0.11± 0.16 0.45±0.27 0.40±0.11 0.33±0.09 0.15±0.08
Intercept 29.4±29.2 73.6±21.8 52.2±36.3 46.8±14.8 37.5±11.7 66.3±11.4
FIGURE 2: Linear regression lines between normalised cerebral
blood flow (expressed as % baseline) and mean arterial pressure
(mmHg) in awake sheep (closed circles) and during steady state
isoflurane anaesthesia (2%) (open circles) during infusions of
adrenaline, noradrenaline and dopamine. Catecholamines have
been pooled in each cohort.
TABLE 2
Summary of the analysis of covariance comparing the differences 
in the slope and intercepts of the regression lines for individual
catecholamines in awake sheep and during steady-state isoflurane
anaesthesia (2%). Data are the P values for individual regression
comparisons. (*) indicates significant results where P<0.05
Awake Isoflurane 
Comparison Slope Intercept Slope Intercept
Adrenaline v noradrenaline 0.16 0.08 0.65 0.002*
Adrenaline v dopamine 0.84 0.06 0.15 0.03*
Dopamine v noradrenaline 0.36 0.01* 0.23 0.12
perturbation. In order to determine this relationship,
stability of the metabolic components of autoregula-
tion were standardized. These metabolic components
include arterial and cerebral carbon dioxide tension,
systemic and cerebral oxygen consumption and
temperature. 
In a study using the same animal preparation, we
determined carbon dioxide reactivity in awake sheep
and under steady-state propofol anaesthesia15. This
study demonstrated that over a range of arterial car-
bon dioxide tensions from 18 to 63 mmHg, carbon
dioxide reactivity under propofol was significantly
different from that in awake sheep. To remove the in-
fluences of carbon dioxide on cerebral autoregula-
tion, studies under anaesthesia were conducted 
using mechanical ventilation, so that arterial carbon
dioxide tensions and pH were maintained at normal
levels. Accordingly, cerebral blood flow data
measured during the ramped infusions of adrenaline,
noradrenaline and dopamine were normalized to an
arterial carbon dioxide tension of 35 mmHg. 
We have quantified the systemic and cerebral
metabolic effects of catecholamines in awake sheep
and under propofol anaesthesia16. Whilst propofol
anaesthesia decreases cerebral oxygen consumption
relative to systemic levels, no difference between the
catecholamines was demonstrated. Temperature was
maintained at a constant level throughout the studies. 
Over a specified dose range, adrenaline, nor-
adrenaline and dopamine induced equivalent, signifi-
cant systemic hypertension in awake sheep and
during isoflurane anaesthesia. 
In the presence of catecholamine-induced systemic
hypertension, the effects on cerebral blood flow
under these two states were slightly different. Whilst
adrenaline caused a moderate, but statistically sig-
nificant increase in cerebral blood flow in the awake
cohort, noradrenaline and dopamine did not increase
cerebral blood flow. Under isoflurane anaesthesia,
which did not significantly alter cerebral blood flow
or mean arterial pressure from baseline, none of the
catecholamines increased cerebral blood flow. 
Analysing each cohort separately, there was no sig-
nificant difference between the effect of adrenaline,
noradrenaline and dopamine on cerebral blood flow
within each cohort. 
The autoregulatory curves define these effects. The
slope of the cerebral blood flow/mean arterial pres-
sure regression line is representative of the degree of
autoregulation. Maintenance of a horizontal line
represents the ability to maintain cerebral blood flow
at a constant rate over a range of increasing blood
pressure. Elevation of the slope represents progres-
sive exhaustion of autoregulatory capacity to a point
where cerebral blood flow ultimately becomes depen-
dent on mean arterial pressure. Despite qualitative
differences between the effects of the catecholamines
under awake and isoflurane anaesthesia, there was no
difference between the slopes of the regression lines
in these cohorts. The major difference was demon-
strated in the intercept of the regression lines. This
correlated to the small but non-significant reduction
in cerebral blood flow induced by isoflurane com-
pared to the awake state (i.e. 88.45% of baseline).
These findings suggest that cerebral blood flow and
autoregulation is preserved under isoflurane anaes-
thesia similar to the awake state, during cate-
cholamine-induced hypertension. 
Studies of cerebral autoregulatory function under
isoflurane anaesthesia have been conducted using
various methods of measurement of cerebral blood
flow/mean arterial pressure relationships. Ideally,
these measurements should be simultaneous and con-
tinuous, thereby assessing the response of the depen-
dent variable (cerebral blood flow) over a range of
cerebral perfusion pressures.
Similarly, autoregulatory relationships have been
determined a number of methods. These include
regression analysis between mean arterial pressure
and cerebral blood flow3 or cerebrovascular resis-
tance17, dynamic and static measurements of cerebral
blood flow responses to changes in mean arterial
pressure18,19, and derived indices such as the auto-
regulatory index20. 
Isoflurane anaesthesia causes a relative increase in
cerebral blood flow by uncoupling flow and metabo-
lism10,11,21. As this phenomenon is directly dose and
time dependent4,10, interpretation and comparisons of
studies of autoregulatory function requires consider-
ation of dose, duration of anaesthesia and methods of
measurements. Consequently, there are diverse con-
clusions about the effects of isoflurane anaesthesia on
cerebral autoregulation.
In a lapine preparation, Patel studied the effects of
induced hypertension by angiotensin II, noradrena-
line and phenylephrine on global and regional cere-
bral blood flows (measured by radioactive micro-
spheres) during 1.0 MAC isoflurane anaesthesia5.
The slopes of pressure/flow curves produced by nor-
adrenaline and phenylephrine were significantly
steeper than that produced by angiotensin II in all
cerebral blood flow regions. Patel concluded that
noradrenaline and phenylephrine caused indirect
cerebral vasodilation, whilst angiotensin II caused
vasoconstriction during 1.0 MAC isoflurane. How-
ever, deductions about specific vascular effects of
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vasoactive agents from the slope of regression curves
must be made with circumspection. Factors that
determine autoregulatory relationships are more
complex than solely attributing changes to vaso-
reactivity. The difference in the conclusion from our
study may, in part, be explained by the difference 
in cerebral blood flow measurement—intermittent
(microsphere) versus continuous (sagittal sinus
Doppler). 
There are few controlled studies of the effects 
of isoflurane on autoregulation in humans. Strebel
assessed alterations in dynamic autoregulation from
the response of middle cerebral artery blood flow
velocities in patients anaesthetized with low (0.5
MAC) and high (1.5 MAC) dose isoflurane18.
Transient step increases and decreases in mean
arterial pressure were induced by infusions of
phenylephrine and rapid inflation/deflation of thigh
cuffs respectively. Patients were compared to those
having baseline anaesthesia with fentanyl and
nitrous oxide. The study demonstrated that low dose
isoflurane delayed autoregulatory responses to
changes in systemic blood pressure, whilst high dose
isoflurane ablated autoregulation. This study was
limited by lack of an intact autoregulatory baseline,
the use of intermittent indirect measurements of
cerebral blood flow and derived variables for the
assessment of autoregulation. However, it does
emphasise the importance of dose and autoregu-
latory function. In our study, steady-state concen-
trations of isoflurane were used for standard periods
of time that demonstrated baseline stability and
allowed inter-cohort comparisons. 
In another human study, Strebel compared the
influence of phenylephrine and noradrenaline blood
flow velocities of the middle cerebral and internal
carotid arteries, measured by transcranial Doppler,
during isoflurane anaesthesia22. Following augmenta-
tion of mean arterial pressure by 20%, flow velocities
were determined in the supine and head-up position.
Whilst noradrenaline and phenylephrine significantly
increased mean flow velocities in the supine position,
these effects were negated in the head-up position.
Strebel concluded that these vasoactive agents did
not directly affect intracranial haemodynamics 
under isoflurane anaesthesia, but rather that the
observed haemodynamic changes reflected the effect
of isoflurane on cerebral pressure autoregulation.
Engelhard compared the effects of 1.5 MAC iso-
flurane on dynamic cerebrovascular autoregulation
compared to the awake state in humans17. This was
assessed using transcranial Doppler ultrasonography
and by deriving an autoregulatory index from an
induced change in systemic blood pressure. Auto-
regulatory responses were delayed under isoflurane
anaesthesia compared to the awake state. The dif-
ference in our study may be explained by the effects
that catecholamines may have on the cerebral vas-
culature under isoflurane anaesthesia. This has been
attributed to isoflurane induced changes in cerebral
blood flow and blood-brain barrier permeability10,11,23
and by the catecholamines themselves if associated
induced hypertension exceeds the upper auto-
regulatory threshold24,25.
The results of our study require the following con-
siderations. We have previously described the effects
of adrenaline noradrenaline and dopamine on cere-
bral blood flow using a higher dosing regimen. In that
study, the drugs were infused to peak doses of 60 ml/h
for adrenaline and noradrenaline and 60 ml/h for
dopamine26. At these doses, dopamine significantly
increased cerebral blood flow from baseline. In the
current analysis, we limited the dose to 40 ml/h so
that linearity between cerebral blood flow and mean
arterial pressure was maintained. At higher doses, it
is probable that the relationship is non-linear. 
Second, we determined regression lines using
pooled data for each study rather than individual
data. This was done to minimize inter-animal
variability. 
Third, mean arterial pressure was used as an index
of cerebral perfusion pressure. As this was a physio-
logical study conducted in the absence of antecedent
raised intracranial pressure and normocapnia, this is
an acceptable assumption. However, direct effects of
catecholamines on intracranial pressure, once upper
autoregulatory thresholds have been exhausted, may
be a confounding variable that was not quantified.
There are clinical applications from this animal
study. Patients with altered cerebral blood flow and
autoregulatory capacity are frequently anaesthetized
with isoflurane, (e.g. following traumatic brain injury
and aneurysmal subarachnoid haemorrhage). The
combination of isoflurane and any of three cate-
cholamines studied did not appear to significantly
alter cerebral blood flow or autoregulation in the
dose ranges that were analysed. Despite recognised
cerebral vasodilatory effects of isoflurane, and poten-
tial vascular effects of the catecholamines under
isoflurane anaesthesia, there did not appear to be
alterations in autoregulatory capacity in this prepara-
tion. However, extrapolations of the results from this
study to pathophysiological states are speculative and
warrant further study.
In conclusion, over a specific dose range, induced
systemic hypertension by adrenaline, noradrenaline
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and dopamine did not significantly increase cerebral
blood flow under 2% isoflurane anaesthesia. The
concomitant administration of isoflurane and the
catecholamines was not associated with altered
autoregulatory function compared to awake sheep. 
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